Cancer Blood Test
AMAS, an antibody-based blood test touted in the 1990s as a one-drop cancer screen, generated early excitement but never achieved mainstream clinical validation. Modern screening now focuses on validated imaging, tissue diagnostics, and DNA-based liquid biopsies under rigorous study.